Showing results (951-960 of 1,068) with videos related to
Sort By:
Pageof 107
Journal of Pharmacokinetics and Pharmacodynamics|December 10, 2013
Evaluation of bootstrap methods for estimating uncertainty of parameters in nonlinear mixed-effects models: a simulation study in population pharmacokineticsHoai-Thu Thai, France Mentré, Nicholas H G Holford, et al.Journal of Pharmacokinetics and Pharmacodynamics|April 18, 2013
Disease progression and neuroscienceNick HolfordJournal of Pharmacokinetics and Pharmacodynamics|March 30, 2013
The impact of P-gp functionality on non-steady state relationships between CSF and brain extracellular fluidJoost Westerhout, Jean Smeets, Meindert Danhof, et al.Journal of Pharmacokinetics and Pharmacodynamics|March 5, 2013
Development of a placebo effect model combined with a dropout model for bipolar disorderWan Sun, Thomas P Laughren, Hao Zhu, et al.Journal of Pharmacokinetics and Pharmacodynamics|January 1, 2013
Variability and singularity arising from poor compliance in a pharmacokinetic model I: the multi-IV casePierre-Emmanuel Lévy Véhel, Jacques Lévy VéhelJournal of Pharmacokinetics and Pharmacodynamics|January 1, 2013
Latent variable indirect response modeling of categorical endpoints representing change from baselineChuanpu Hu, Zhenhua Xu, Alan M Mendelsohn, et al.Journal of Pharmacokinetics and Pharmacodynamics|September 21, 2014
An immunology primer for computational modelersWilliam F Hawse, Penelope A MorelJournal of Pharmacokinetics and Pharmacodynamics|October 5, 2014
Continuous-time Markov modelling of flexible-dose depression trialsEleonora Marostica, Alberto Russu, Roberto Gomeni, et al.Journal of Pharmacokinetics and Pharmacodynamics|August 2, 2015
Application of a Bayesian approach to physiological modelling of mavoglurant population pharmacokineticsThierry Wendling, Swati Dumitras, Kayode Ogungbenro, et al.Journal of Pharmacokinetics and Pharmacodynamics|December 15, 2015
What do we mean by identifiability in mixed effects models?Marc Lavielle, Leon AaronsPageof 107